awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38937759-53770931-D46D-4ED6-A2F3-DEEF9701DAAB
Q38937759-53770931-D46D-4ED6-A2F3-DEEF9701DAAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38937759-53770931-D46D-4ED6-A2F3-DEEF9701DAAB
Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
P2860
Q38937759-53770931-D46D-4ED6-A2F3-DEEF9701DAAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38937759-53770931-D46D-4ED6-A2F3-DEEF9701DAAB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00e3c87c8cec15e9f5c425604283d53262ec0ed5
P2860
Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC).